| PRECLINICAL | evidence | Synthesis and Characterization of Injectable Hydrogels with Varying Collagen(-)Chitosan(-)Thymosin beta4 Composition for Myocardial Infarction Therapy. | Thymosin beta 4 | — | 2018-04-30 |
| PRECLINICAL | evidence | Rapid production of pure recombinant actin isoforms in Pichia pastoris. | Thymosin β4 | — | 2018-04-23 |
| PRECLINICAL | evidence | Molecular Motions and Interactions in Aqueous Solutions of Thymosin-beta(4) , Stabilin C-Terminal Domain (CTD) and Their 1:1 Complex Studied by (1) H NMR Spectroscopy. | Tbeta4 | — | 2018-04-05 |
| PRECLINICAL | evidence | Glutathione depletion triggers actin cytoskeleton changes via actin-binding proteins. | Thymosin β4 | — | 2018-04-01 |
| PRECLINICAL | evidence | Thymosin beta4 Reduces H(2)O(2) Induced Oxidative Stress in MC3T3-E1 Cells on Titanium Surface. | Tbeta4 | Longevity & cellular aging · preclinical | 2018-02-01 |
| PRECLINICAL | evidence | Reconsidering an active role for G-actin in cytoskeletal regulation. | Thymosin beta 4 | — | 2018-01-10 |
| PRECLINICAL | evidence | Expression and localisation of thymosin beta-4 in the developing human early fetal heart. | Tbeta4 | — | 2018-01-01 |
| PRECLINICAL | evidence | Serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitis. | Tbeta4 | Liver health | 2018-01-01 |
| PRECLINICAL | evidence | Thymosin-beta4 Mediates Hepatic Stellate Cell Activation by Interfering with CircRNA-0067835/miR-155/FoxO3 Signaling Pathway. | Tbeta4 | Liver health | 2018-01-01 |
| PRECLINICAL | evidence | Highly effective biosynthesis of N-acetylated human thymosin beta4 (Tbeta4) in Escherichia coli. | Tbeta4 | Eye & vision health | 2018-01-01 |
| PRECLINICAL | evidence | Thymosin beta4 attenuates liver fibrosis via suppressing Notch signaling. | Tbeta4 | Liver health | 2017-12-02 |
| PRECLINICAL | evidence | Engineered M13 Nanofiber Accelerates Ischemic Neovascularization by Enhancing Endothelial Progenitor Cells. | Thymosin β4 | — | 2017-12-01 |
| PRECLINICAL | evidence | Adsorption effects of the doping relevant peptides Insulin Lispro, Synachten, TB-500 and GHRP 5. | TB 500 | — | 2017-11-15 |
| PRECLINICAL | evidence | Ocular Effects of Sulfur Mustard and Therapeutic Approaches. | Thymosin β4 | Eye & vision health | 2017-11-01 |
| PRECLINICAL | evidence | Thymosin beta4 alleviates renal fibrosis and tubular cell apoptosis through TGF-beta pathway inhibition in UUO rat models. | Tbeta4 | — | 2017-10-18 |
| PRECLINICAL | evidence | Steerable Induction of the Thymosin beta4/MRTF-A Pathway via AAV-Based Overexpression Induces Therapeutic Neovascularization. | Tbeta4 | — | 2017-10-03 |
| PRECLINICAL | evidence | Thymosin-beta4 inhibits proliferation and induces apoptosis of hepatic stellate cells through PI3K/AKT pathway. | Tbeta4 | — | 2017-09-15 |
| PRECLINICAL | evidence | Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease. | Tbeta4 | — | 2017-09-01 |
| PRECLINICAL | evidence | Thymosin beta4 in rheumatoid arthritis: Friend or foe. | Tbeta4 | — | 2017-09-01 |
| PRECLINICAL | evidence | MiR-200a mediates protection of thymosin beta 4 in cardiac microvascular endothelial cells as a novel mechanism under hypoxia-reoxygenation injury. | Tbeta4 | — | 2017-08-31 |
| PRECLINICAL | evidence | Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma. | Thymosin beta 4 | — | 2017-08-22 |
| PRECLINICAL | evidence | In vivo dynamics of the cortical actin network revealed by fast-scanning atomic force microscopy. | Thymosin beta 4 | — | 2017-08-01 |
| PRECLINICAL | evidence | A loss of profilin-1 in late-stage oral squamous cell carcinoma. | Thymosin beta 4 | preclinical | 2017-08-01 |
| PRECLINICAL | evidence | BRG1-SWI/SNF-dependent regulation of the Wt1 transcriptional landscape mediates epicardial activity during heart development and disease. | Tbeta4 | — | 2017-07-24 |
| PRECLINICAL | evidence | Tumor suppressor miR-1 inhibits tumor growth and metastasis by simultaneously targeting multiple genes. | Thymosin beta 4 | — | 2017-06-27 |
| PRECLINICAL | evidence | Thymosin Beta-4 Is Elevated in Women With Heart Failure With Preserved Ejection Fraction. | Thymosin beta 4 | — | 2017-06-13 |
| PRECLINICAL | evidence | Acquired Resistance with Epigenetic Alterations Under Long-Term Antiangiogenic Therapy for Hepatocellular Carcinoma. | Tbeta4 | — | 2017-06-01 |
| PRECLINICAL | evidence | Proteomics in pediatric cystic craniopharyngioma. | Thymosin β4 | — | 2017-05-01 |
| PRECLINICAL | evidence | Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis. | Thymosin beta 4 | preclinical | 2017-05-01 |
| PRECLINICAL | evidence | Endogenous Thymosin beta4 Expression in Sacrococcygeal Pilonidal Sinus Disease: A Retrospective, Immunohistochemical Analysis of Excisional Skin Biopsy Samples. | Tbeta4 | — | 2017-04-01 |
| PRECLINICAL | evidence | Preventive Effects of Poloxamer 188 on Muscle Cell Damage Mechanics Under Oxidative Stress. | Thymosin beta 4 | Longevity & cellular aging | 2017-04-01 |
| PRECLINICAL | evidence | Thymosin beta4 has a major role in dermal burn wound healing that involves actin cytoskeletal remodelling via heat-shock protein 70. | Tbeta4 | Wound healing | 2017-04-01 |
| PRECLINICAL | evidence | MALDI imaging mass spectrometry analysis-A new approach for protein mapping in multiple sclerosis brain lesions. | Thymosin beta 4 | — | 2017-03-15 |
| PRECLINICAL | evidence | The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation. | Thymosin beta 4 | — | 2017-03-01 |
| PRECLINICAL | evidence | Diabetes Mellitus-Induced Microvascular Destabilization in the Myocardium. | Tbeta4 | — | 2017-01-17 |
| PRECLINICAL | evidence | p49/STRAP, a Serum Response Factor Binding Protein (SRFBP1), Is Involved in the Redistribution of Cytoskeletal F-Actin Proteins during Glucose Deprivation. | Thymosin β4 | — | 2017-01-01 |
| PRECLINICAL | evidence | ADP-Ribosylation and Cross-Linking of Actin by Bacterial Protein Toxins. | Thymosin β4 | — | 2017-01-01 |
| PRECLINICAL | evidence | Actin ADP-ribosylation at Threonine148 by Photorhabdus luminescens toxin TccC3 induces aggregation of intracellular F-actin. | Thymosin β4 | — | 2017-01-01 |
| PRECLINICAL | evidence | Thymosin beta4 Improves Differentiation and Vascularization of EHTs. | Tbeta4 | — | 2017-01-01 |
| PRECLINICAL | evidence | Increased Expression of Thymosin beta(4) Is Independently Correlated with Hypoxia Inducible Factor-1alpha (HIF-1alpha) and Worse Clinical Outcome in Human Colorectal Cancer. | Thymosin beta 4 | — | 2017-01-01 |
| PRECLINICAL | evidence | Evaluation of the physiological activity of venom from the Eurasian water shrew Neomys fodiens. | Thymosin β4 | — | 2017-01-01 |
| PRECLINICAL | evidence | Approaches to augment vascularisation and regeneration of the adult heart via the reactivated epicardium. | Thymosin β4 | — | 2016-12-30 |
| PRECLINICAL | evidence | The Hidden Function of Vitamin D. | Thymosin beta 4 | — | 2016-12-15 |
| PRECLINICAL | evidence | Crenactin forms actin-like double helical filaments regulated by arcadin-2. | Thymosin β4 | — | 2016-11-17 |
| PRECLINICAL | evidence | Thymosin beta as an Actin-binding Protein with a Variety of Functions. | Tbeta4 | — | 2016-11-01 |
| PRECLINICAL | evidence | Loss of endogenous thymosin beta(4) accelerates glomerular disease. | Thymosin beta 4 | Liver health | 2016-11-01 |
| PRECLINICAL | evidence | Comparison of various in vitro model systems of the metabolism of synthetic doping peptides: Proteolytic enzymes, human blood serum, liver and kidney microsomes and liver S9 fraction. | TB 500 | — | 2016-10-21 |
| PRECLINICAL | evidence | Thymosin beta(4) and beta(10) in Sjogren's syndrome: saliva proteomics and minor salivary glands expression. | Tbeta4 | Immune function · n = 61 | 2016-10-06 |
| PRECLINICAL | evidence | The TMSB4 Pseudogene LncRNA Functions as a Competing Endogenous RNA to Promote Cartilage Degradation in Human Osteoarthritis. | Thymosin beta 4 | Bone & joint health · preclinical · n = 50 | 2016-10-01 |
| PRECLINICAL | evidence | Utilization of paramagnetic relaxation enhancements for structural analysis of actin-binding proteins in complex with actin. | Tbeta4 | — | 2016-09-22 |